Deutsch Barry M. 4
4 · XERIS PHARMACEUTICALS INC · Filed Feb 1, 2019
Insider Transaction Report
Form 4
Deutsch Barry M.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-31+25,000→ 25,000 totalExercise: $13.88Exp: 2029-01-31→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]25% of these shares shall vest on the first anniversary of the vesting commencement date, with the remainder vesting ratably over the following 36 months.